glp-1 growth Receptor Agonist Market Size, Trends and Share Report 2026 GLP-1 Receptor Agonist Market Report:

If you want a deeper look at the mechanisms behind these changes, our guide on why GLP-1 medications cause GI issues breaks it down further

Hypoactive Sexual Desire Disorder (HSDD) in Women Dosage: 1.75 mg per injection, used as needed (FDA-approved dose for HSDD) Cycle: Used on demand, up to 8 times per month Administration: SC injection Stacking: Can be used with hormonal therapies or testosterone in postmenopausal women Expected Benefits: Increased sexual desire and responsiveness, reduced psychological distress related to low libido 4

From GLP-1 medications to nutritional counseling, fitness classes, and body contouring, our holistic services are designed to support every step of your transformation journey

Harris RC, Foster CVL, Hultman E